<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03320993</url>
  </required_header>
  <id_info>
    <org_study_id>DPI2016-78831-C2-1-R_alcohol</org_study_id>
    <nct_id>NCT03320993</nct_id>
  </id_info>
  <brief_title>Impact of Meal Composition and Alcohol Consumption on Postprandial Glycemic Control in Subjects With Type 1 Diabetes</brief_title>
  <official_title>Evaluación Del Impacto de la composición Nutricional de la Ingesta y Del Consumo de Alcohol en el Control glucémico Postprandial en Pacientes Con Diabetes Tipo 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jorge Bondia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Francesc de Borja, Gandia, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spanish Ministry of Economy, Industry and Competitiveness</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitat Politècnica de València</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postprandial glucose control is a challenging issue in everyday diabetes care. Indeed,
      excessive postprandial glucose excursions are the major contributors to plasma glucose (PG)
      variability in subjects with type 1 diabetes (T1DM). In addition, the poor reproducibility of
      postprandial glucose response is burdensome for patients and healthcare professionals.

      To date, the majority of prandial insulin dosing algorithms for subjects with T1DM considers
      only the carbohydrate (CHO) content of the meal. However, there is evidence (although with a
      certain degree of heterogeneity) that meal composition significantly affects postprandial
      glucose control, contributing to glycemic variability. Moreover, despite the high prevalence
      of alcohol consumption among patients with T1DM (about 30%, similar to that of the general
      population), data regarding its effect on the postprandial period are very limited.

      This project will evaluate the effect of meal composition and alcohol consumption on
      postprandial glucose control in subjects with T1DM under intensive insulin treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, prospective, single-centre (Hospital Francesc de Borja, Gandia, Spain),
      single-blind (analysis), three -way, crossover study on type 1 diabetic subjects (n=12) under
      intensive insulin treatment.

      Aim:

      To assess the effect of mixed meal composition on postprandial glycemic control, in subjects
      with type 1 diabetes:

        1. Combined effect of proteins and fats

        2. Effect of alcohol consumption

      Methods:

      Each subject will undergo three mixed meal test studies (on three different days), with
      identical CHO content: On one occasion a low fat-low protein meal will be given, and on
      another a high fat-high protein one, both consumed with a non-alcoholic drink; on a third
      occasion the same high fat-high protein meal will be consumed, but this time accompanied by
      an equal volume of an alcoholic drink.

      Patients will arrive at the research unit at 8:00 am and their blood glucose will be
      stabilized around 90 mg/dl before each mixed meal test. After the mixed meal, blood will be
      drawn every 5-30 min during a 6 hour post-prandial period to assess plasma glucose, hormones
      and metabolites concentration.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>3-period, 3-treatment crossover design</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Data analysis will be carried out by a person not involved in the study (she/he will be blind to the study condition)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Glucose</measure>
    <time_frame>6 hours (plasma glucose will be measured every 5-15 minutes during the 6-hour post-prandial period of each mixed meal test).</time_frame>
    <description>Post-prandial plasma glucose time series</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC-PG</measure>
    <time_frame>AUC of plasma glucose will be calculated for the whole 6 hour post-prandial period, for the early 0-3 hour post-prandial period and for the late 3-6 hour post-prandial period.</time_frame>
    <description>Area Under the Curve (AUC) of Plasma Glucose in the 0-6h, 0-3h and 3-6h post-prandial periods</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time in range</measure>
    <time_frame>6 hours (time in range during the 6 hour post-prandial period)</time_frame>
    <description>Time in acceptable glucose range (70-180 mg/dl)</description>
  </other_outcome>
  <other_outcome>
    <measure>C Max</measure>
    <time_frame>6 hours (maximum plasma glucose concentration during the 6 hour post-prandial period)</time_frame>
    <description>Maximum of plasma glucose concentration</description>
  </other_outcome>
  <other_outcome>
    <measure>T max</measure>
    <time_frame>6 hours (Time of maximum plasma glucose concentration during the 6 hour post-prandial period)</time_frame>
    <description>Time of Maximum plasma glucose concentration</description>
  </other_outcome>
  <other_outcome>
    <measure>Hormones and metabolites</measure>
    <time_frame>6 hours (plasma hormones and metabolites will be measured every 30 minutes during the 6-hour post-prandial period)</time_frame>
    <description>Plasma concentration of free fatty acids, beta-OH-butyrate, lactate, alanine, counterregulatory hormones</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>Low Protein-Low Fat study</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive a mixed meal with carbohydrates (70g) plus a low content of proteins and fats</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Protein-High Fat study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive a mixed meal with the same carbohydrates content of arm 1 (70g), but a greater amount of fats and proteins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Protein-High Fat &amp; alcohol study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive the same mixed meal of the High Protein-High Fat study plus 0,7g of alcohol per Kg of weight</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mixed meal with different macronutrient composition</intervention_name>
    <description>A mixed meal with identical amount of carbohydrates but different content of protein, fat and alcohol will be given</description>
    <arm_group_label>Low Protein-Low Fat study</arm_group_label>
    <arm_group_label>High Protein-High Fat study</arm_group_label>
    <arm_group_label>High Protein-High Fat &amp; alcohol study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with type 1 diabetes mellitus for more than one year, aged between 18 and 60
        years; on intensive insulin therapy by means of CSII (continuous subcutaneous insulin
        infusion) or MDI (multiple daily injections) for at least 6 months before screening;
        glycosylated haemoglobin of 6-8.5%; without severe chronic micro- and macroangiopathic
        diabetic complications and with a body mass index (BMI) between 18 and 30 kg/m2.

        Exclusion Criteria:

          -  Pregnancy and lactation

          -  Hypoglycemia unawareness

          -  Fatal or progressive disease

          -  Drugs or alcohol abuse

          -  HIV, active hepatitis B, active hepatitis C

          -  Hepatic disease (aminotransferases AST or ALT &gt;2 times above normal)

          -  Clinically relevant microangiopathic disease, or other diseases that may interfere
             with participation in the study or data analysis

          -  Pre-planned surgery

          -  Blood donation in the previous 3 months for men and 6 months for women

          -  Mental conditions that may interfere with the subject's comprehension of the aims and
             possible consequences of the study

          -  Non-compliant subjects

          -  Use of experimental medications or devices during the previous 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Rossetti, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Francesc de Borja, Gandia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge Bondia Company, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universitat Politècnica de València</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paolo Rossetti, PhD</last_name>
    <phone>0034608109913</phone>
    <email>prossetti73@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jorge Bondia Company, PhD</last_name>
    <phone>0034963877007</phone>
    <phone_ext>75762</phone_ext>
    <email>jbondia@isa.upv.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Francesc de Borja</name>
      <address>
        <city>Gandia</city>
        <state>Valencia</state>
        <zip>46072</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Rossetti, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Agustin Ramos Prol, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alia García Castells, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015 Jun;38(6):1008-15. doi: 10.2337/dc15-0100. Review.</citation>
    <PMID>25998293</PMID>
  </reference>
  <reference>
    <citation>Bell KJ, Toschi E, Steil GM, Wolpert HA. Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management. Diabetes Care. 2016 Sep;39(9):1631-4. doi: 10.2337/dc15-2855. Epub 2016 Jul 7.</citation>
    <PMID>27388474</PMID>
  </reference>
  <reference>
    <citation>Barnard K, Sinclair JM, Lawton J, Young AJ, Holt RI. Alcohol-associated risks for young adults with Type 1 diabetes: a narrative review. Diabet Med. 2012 Apr;29(4):434-40. doi: 10.1111/j.1464-5491.2012.03579.x. Review.</citation>
    <PMID>22248115</PMID>
  </reference>
  <reference>
    <citation>Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care. 2001 Nov;24(11):1888-93.</citation>
    <PMID>11679452</PMID>
  </reference>
  <reference>
    <citation>Kerr D, Cheyne E, Thomas P, Sherwin R. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes. Diabet Med. 2007 Mar;24(3):312-6.</citation>
    <PMID>17263767</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2017</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitat Politècnica de València</investigator_affiliation>
    <investigator_full_name>Jorge Bondia</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>post-prandial glucose control</keyword>
  <keyword>alcohol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

